Subject:
|
DCN 1: Perception and Action DCN 2: Functional Neurogenomics EBP 1: Determinants of Health and Disease EBP 3: Effective Primary Care and Public Health NCEBP 10: Human Movement & Fatigue NCEBP 8: Psychological determinants of chronic illness ONCOL 4: Quality of Care UMCN 3.1: Neuromuscular development and genetic disorders UMCN 4.1: Microbial pathogenesis and host defense EBP 1: Determinants of Health and Disease NCEBP 10: Human Movement & Fatigue |
Organization:
|
Medical Psychology Internal Medicine Neurology |
Journal title:
|
Acta Neurologica Scandinavica
|
Abstract:
|
OBJECTIVES: To study the presence of psychiatric comorbidity assessed by the use of a structured clinical interview and self-reported questionnaires in a large sample of patients with adult-onset myotonic dystrophy (DM), facioscapulohumeral muscular dystrophy (FSHD), and hereditary motor and sensory neuropathy type I (HMSN-I), and to assess whether psychiatric comorbidity is related to fatigue severity and/or muscle strength. METHODS: In a cohort of 217 patients with a neuromuscular disorder (79 DM, 65 FSHD and 73 HMSN-I patients) overall psychiatric comorbidity was studied cross-sectionally with the structured clinical interview for DSM-IV axis I disorders. Self-reported psychopathology, fatigue severity and muscle strength were assessed with the Beck Depression Inventory, Symptom Checklist-90, General Health Questionnaire-12, Checklist Individual Strength and muscle strength [Medical Research Council (MRC)-scale]. RESULTS: In all three neuromuscular disorders (DM, FSHD and HMSN), 10-12% of the patients met DSM IV clinical criteria for current psychiatric disorders. Lifetime psychiatric disorders were found in 32% of patients in all three patient groups. The most common psychiatric disorders were depression and phobias. A comparison of patients with and without current psychiatric disorder showed that fatigue severity and muscle strength (MRC) were not related to psychiatric comorbidity. CONCLUSION: Psychiatric disorders appear equally in patients with DM, FSHD and HMSN-I and are not related to fatigue or muscle strength in these patients.
|